Best Stocks Under $20 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $20.00 (20 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Galp Energia SGPS OTCMKTS:GLPEY$9.66 -0.02 (-0.16%) As of 08/29/2025 03:51 PM EasternGalp Energia, SGPS, SA operates as an integrated energy operator in Portugal and internationally. The company operates through four segments: Upstream, Industrial & Midstream, Commercial, and Renewables and New Business. More about Galp Energia SGPSMarket Capitalization$13.45 billionP/E Ratio13.60Consensus RatingStrong BuyVolume62,198 sharesAverage Volume29,772 sharesToday's Range$9.64▼$9.69 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Birchcliff Energy OTCMKTS:BIREF$4.59 0.00 (-0.02%) As of 08/29/2025 03:31 PM EasternBirchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff EnergyMarket Capitalization$1.25 billionP/E Ratio24.15Consensus RatingStrong BuyVolume4,160 sharesAverage Volume21,557 sharesToday's Range$4.59▼$4.633. Ivanhoe Mines OTCMKTS:IVPAF$8.84 +0.34 (+3.99%) As of 08/29/2025 03:58 PM EasternIvanhoe Mines Ltd. engages in the mining, development, and exploration of minerals and precious metals primarily in Africa. More about Ivanhoe MinesMarket Capitalization$11.51 billionP/E Ratio17.87Consensus RatingStrong BuyVolume149,850 sharesAverage Volume242,820 sharesToday's Range$8.49▼$8.884. Artelo Biosciences NASDAQ:ARTL$9.25 +0.21 (+2.32%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$9.37 +0.12 (+1.30%) As of 08/29/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Artelo Biosciences, Inc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. More about Artelo BiosciencesMarket Capitalization$6.37 millionP/E Ratio-0.49Consensus RatingStrong BuyConsensus Price Target$24.00 (+159.5% Upside)Volume13,417 sharesAverage Volume108,888 shares5. Glencore OTCMKTS:GLNCY$7.86 -0.14 (-1.75%) As of 08/29/2025 03:59 PM EasternGlencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, and energy products in the Americas, Europe, Asia, Africa, and Oceania. More about GlencoreMarket Capitalization$47.63 billionConsensus RatingStrong BuyVolume430,118 sharesAverage Volume760,091 sharesToday's Range$7.77▼$7.8650-Day Range$7.43▼$8.846. Reckitt Benckiser Group OTCMKTS:RBGLY$15.05 +0.08 (+0.53%) As of 08/29/2025 03:59 PM EasternReckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands. More about Reckitt Benckiser GroupMarket Capitalization$50.75 billionConsensus RatingBuyVolume192,576 sharesAverage Volume240,049 sharesToday's Range$14.96▼$15.0650-Day Range$13.48▼$15.207. Senseonics NYSE:SENS$0.46 0.00 (-0.11%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.46 0.00 (-0.54%) As of 08/29/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. More about SenseonicsMarket Capitalization$374.35 millionP/E Ratio-3.53Consensus RatingBuyConsensus Price Target$1.54 (+234.6% Upside)Volume3.11 million sharesAverage Volume8.04 million shares8. Ultrapar Participacoes NYSE:UGP$3.66 -0.05 (-1.22%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$3.62 -0.03 (-0.93%) As of 08/29/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ultrapar Participações SA, through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers, in addition to renewable electricity and compressed natural gas. More about Ultrapar ParticipacoesMarket Capitalization$4.13 billionP/E Ratio8.12Consensus RatingBuyConsensus Price Target$3.20 (-12.4% Downside)Volume2.04 million sharesAverage Volume1.58 million shares9. TuHURA Biosciences NASDAQ:HURA$2.70 -0.11 (-3.91%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$2.72 +0.02 (+0.74%) As of 08/29/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA BiosciencesMarket Capitalization$140.63 millionConsensus RatingBuyConsensus Price Target$12.67 (+369.1% Upside)Volume220,226 sharesAverage Volume796,333 sharesToday's Range$2.69▼$2.8210. Climb Bio NASDAQ:CLYM$2.23 -0.07 (-3.04%) As of 08/29/2025 04:00 PM EasternClimb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. More about Climb BioMarket Capitalization$155.86 millionP/E Ratio-3.19Consensus RatingBuyConsensus Price Target$9.00 (+303.6% Upside)Volume288,883 sharesAverage Volume878,948 shares11. Uranium Energy NYSEAMERICAN:UEC$10.69 +0.21 (+2.00%) Closing price 08/29/2025 04:10 PM EasternExtended Trading$10.66 -0.04 (-0.33%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Uranium Energy Corp., together with its subsidiaries, engages in exploration, pre-extraction, extraction, and processing uranium and titanium concentrates in the United States, Canada, and Paraguay. More about Uranium EnergyMarket Capitalization$4.66 billionP/E Ratio-62.88Consensus RatingBuyConsensus Price Target$10.91 (+2.0% Upside)Volume12.82 million sharesAverage Volume12.73 million shares12. Western Copper & Gold NYSE:WRN$1.41 -0.01 (-0.70%) As of 08/29/2025 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$282.78 millionP/E Ratio-70.50Consensus RatingBuyConsensus Price Target$4.00 (+183.7% Upside)Volume519,590 sharesAverage Volume376,114 shares13. Crescent Biopharma NASDAQ:CBIO$14.40 +0.25 (+1.77%) As of 08/29/2025 04:00 PM EasternCrescent Biopharma, Inc operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. More about Crescent BiopharmaMarket Capitalization$276.63 millionP/E Ratio-0.41Consensus RatingBuyConsensus Price Target$25.60 (+77.8% Upside)Volume49,639 sharesAverage Volume99,205 shares14. Priority Technology NASDAQ:PRTH$8.37 -0.02 (-0.24%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$8.22 -0.15 (-1.73%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Priority Technology Holdings, Inc operates as a payment technology company in the United States. The company operates through three segments: Small and Medium-Sized Businesses (SMB) Payments, Business-To-Business (B2B) Payments, and Enterprise Payments. More about Priority TechnologyMarket Capitalization$670.51 millionP/E Ratio32.19Consensus RatingBuyConsensus Price Target$13.00 (+55.3% Upside)Volume300,329 sharesAverage Volume552,002 shares15. PureCycle Technologies NASDAQ:PCT$14.29 -0.34 (-2.32%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$14.29 0.00 (0.00%) As of 08/29/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PureCycle Technologies, Inc engages in the production of recycled polypropylene (PP). The company holds a license for restoring waste PP into ultra-pure recycled polypropylene resin that has multiple applications, including packaging and labeling for consumer products, piping, ropes, cabling, and plastic parts for various industries. More about PureCycle TechnologiesMarket Capitalization$2.63 billionP/E Ratio-8.46Consensus RatingBuyConsensus Price Target$15.00 (+5.0% Upside)Volume2.25 million sharesAverage Volume3.10 million shares16. Franklin BSP Realty Trust NYSE:FBRT$11.56 +0.20 (+1.72%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$11.48 -0.07 (-0.61%) As of 08/29/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Benefit Street Partners operates as a self-managed real estate investment trust (REIT). BSP earns income from investing in a leveraged portfolio of residential mortgage pass-through securities consisting almost exclusively of adjustable-rate mortgage (ARM) securities issued and guaranteed by government-sponsored enterprises, either Federal National Mortgage Association (Fannie Mae) or Federal Home Loan Mortgage Corporation (Freddie Mac) (together, the government-sponsored enterprises (GSEs)), or by an agency of the federal government, Government National Mortgage Association (Ginnie Mae). More about Franklin BSP Realty TrustMarket Capitalization$934.64 millionP/E Ratio11.79Consensus RatingBuyConsensus Price Target$14.88 (+28.7% Upside)Volume390,850 sharesAverage Volume538,338 shares17. NexGen Energy NYSE:NXE$7.88 +0.44 (+5.95%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$7.86 -0.02 (-0.23%) As of 08/29/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NexGen Energy Ltd., an exploration and development stage company, engages in the acquisition, exploration, and evaluation and development of uranium properties in Canada. More about NexGen EnergyMarket Capitalization$4.25 billionP/E Ratio-31.53Consensus RatingBuyVolume14.24 million sharesAverage Volume6.78 million sharesToday's Range$7.69▼$8.2718. Maze Therapeutics NASDAQ:MAZE$14.49 +0.22 (+1.54%) As of 08/29/2025 04:00 PM EasternWe are a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. More about Maze TherapeuticsMarket Capitalization$625.75 millionConsensus RatingBuyConsensus Price Target$25.60 (+76.7% Upside)Volume358,404 sharesAverage Volume279,721 sharesToday's Range$13.89▼$14.8519. MannKind NASDAQ:MNKD$4.59 +0.10 (+2.23%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$4.61 +0.02 (+0.44%) As of 08/29/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. More about MannKindMarket Capitalization$1.38 billionP/E Ratio41.73Consensus RatingBuyConsensus Price Target$9.50 (+107.0% Upside)Volume4.21 million sharesAverage Volume3.82 million shares20. VNET Group NASDAQ:VNET$8.66 +0.13 (+1.52%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$8.71 +0.05 (+0.58%) As of 08/29/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.VNET Group, Inc, an investment holding company, provides hosting and related services in China. It offers managed hosting services consisting of managed retail services, such as colocation services that dedicate data center space to house customers' servers and networking equipment, as well as allow customers to lease partial or entire cabinets for their servers; interconnectivity services that allow customers to connect their servers; value-added services, including hybrid IT, bare metal, firewall, server load balancing, data backup and recovery, data center management, server management, and backup server services; cloud services that allow customers to run applications over the internet using IT infrastructure; and VPN Services that extend customers' private networks by setting up connections through the public internet. More about VNET GroupMarket Capitalization$2.29 billionP/E Ratio-108.25Consensus RatingBuyConsensus Price Target$9.96 (+15.0% Upside)Volume14.15 million sharesAverage Volume4.96 million shares21. Spyre Therapeutics NASDAQ:SYRE$16.49 -0.23 (-1.38%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$16.48 0.00 (-0.03%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Spyre Therapeutics, Inc, a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). More about Spyre TherapeuticsMarket Capitalization$1.01 billionP/E Ratio-4.85Consensus RatingBuyConsensus Price Target$53.40 (+223.8% Upside)Volume351,933 sharesAverage Volume466,120 shares22. Immunic NASDAQ:IMUX$0.82 -0.05 (-5.75%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.82 +0.00 (+0.37%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about ImmunicMarket Capitalization$85.83 millionP/E Ratio-0.67Consensus RatingBuyConsensus Price Target$7.50 (+814.6% Upside)Volume1.37 million sharesAverage Volume1.09 million shares23. 908 Devices NASDAQ:MASS$6.25 -0.01 (-0.16%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$6.25 0.00 (0.00%) As of 08/29/2025 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. More about 908 DevicesMarket Capitalization$224.49 millionP/E Ratio-11.57Consensus RatingBuyConsensus Price Target$8.00 (+28.0% Upside)Volume231,008 sharesAverage Volume276,047 shares24. Burberry Group OTCMKTS:BURBY$17.44 -0.44 (-2.46%) As of 08/29/2025 03:15 PM EasternBurberry Group plc, together with its subsidiaries, manufactures, retails, and wholesales luxury goods under the Burberry brand. More about Burberry GroupMarket Capitalization$6.42 billionConsensus RatingBuyVolume33,176 sharesAverage Volume87,169 sharesToday's Range$17.24▼$17.6250-Day Range$13.58▼$18.5025. Arlo Technologies NYSE:ARLO$17.42 -0.43 (-2.43%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$17.40 -0.02 (-0.12%) As of 08/29/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Arlo Technologies, Inc, together with its subsidiaries, provides a cloud-based platform in the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions. More about Arlo TechnologiesMarket Capitalization$1.86 billionP/E Ratio-248.76Consensus RatingBuyConsensus Price Target$23.00 (+32.1% Upside)Volume1.58 million sharesAverage Volume1.76 million shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It 3 Reasons Gartner Could Be the Best Buy of Q3 NIO Just Got Its Second Upgrade of the Month, and It’s Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
